3 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Adult Diffuse Large Cell Lymphoma: new trials by email Literature Review of Adult Diffuse Large Cell Lymphoma trials Research Report on Adult Diffuse Large Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 60 | 2021-01-25 | 2026-05-29 |
| DPX-Survivac and Checkpoint Inhibitor in DLBCL DPX-Survivac, Pembrolizumab, Cyclophosphamide 50mg - Adult Diffuse Large Cell Lymphoma, Recurrent | Phase 2 | Completed | Sunnybrook Health Sciences Centre | 25 | 2018-03-13 | 2026-09-25 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia cefepime hydrochloride - Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia | Phase 1 | Completed | Wake Forest University Health Sciences | 70 | 2011-02-01 | 2018-07-18 |
| Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma sunitinib malate - Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 19 | 2007-02-01 | 2014-05-15 |
Lymphoma, Large B-Cell, Diffuse (4) · Burkitt Lymphoma (2) · Hodgkin Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Leukemia, Prolymphocytic (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Lymphoma, Mantle-Cell (2) · Lymphoma, Non-Hodgkin (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Breast Neoplasms (1)
Hemic and Lymphatic Diseases (4) · Disease Attributes (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, B-Cell (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Bone Marrow Diseases (2) · Chronic Disease (2) · DNA Virus Infections (2)
Cyclophosphamide (2) · Cefepime (1) · Cyclosporine (1) · Cyclosporins (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Magnetic Resonance Spectroscopy (1) · Mycophenolic Acid (1) · Stem Cell Transplantation (1) · Sunitinib (1) · Whole-Body Irradiation (1) · fludarabine (1) · pembrolizumab (1) · treosulfan (1)
Fred Hutchinson Cancer Center (1) · National Cancer Institute (NCI) (1) · Sunnybrook Health Sciences Centre (1) · Wake Forest University Health Sciences (1)
Canada (2) · United States (2)
John Williamson (1) · Neil L Berinstein, MD (1) · Phuong Vo, MD (1) · Rena Buckstein (1)